Saccharomyces boulardii is a yeast strain, non-pathogenic in nature, often isolated from the skins of tropical fruits found in Indochina.
It's recognised as a 'probiotic'—a beneficial microorganism that, when ingested, contributes positively to the host's health.
Each capsule of our product contains 5 Billion Colony Forming Units (CFU) of Saccharomyces boulardii, making it a potent tool for preventing and treating diarrhoea. Suitable for vegans, it's a safe and natural way to support your gut health.
The need to know
What are the benefits?
Improves digestive function
Prescribed as standard with antibiotics in most EU countries
Gets rid of “unfriendly” organisms
The beneficial effects of Saccharomyces boulardii stem from its ability to help maintain the balance of healthy intestinal microbiota while inhibiting the growth of harmful bacterial species.
It assists in preserving the intestinal barrier function, preventing the translocation of bacteria from the gut to the bloodstream.
Furthermore, Saccharomyces boulardii is known to stimulate the production of secretory IgA, an essential component of the immune system, thereby enhancing the body's immune response.
How will I know its working?
While individual experiences may vary, users can expect a reduction in instances of diarrhea and overall improvement in gastrointestinal health.
When to take it?
Take 1 capsule daily with food and water, unless specified otherwise on the sachet.
Per Serving% Daily
Olive Leaf (whole leaf equivalent from 10mg extract)
* Percent Daily Values are based on a 2,000 calorie diet.
† Daily Value not established.
Saccharomyces boulardii was initially isolated from the skin of lychee and mangosteen fruits.
Despite being a yeast, it's not affected by antibiotics, making it a beneficial supplement during antibiotic treatment.
It has a proven track record of supporting gut health for over 50 years.
Publications you might find interesting
Want to go a bit deeper?
The latest research
1. McFarland, L.V. (2010). "Systematic review and meta-analysis of Saccharomyces boulardii in adult patients." World Journal of Gastroenterology.
2. Kelesidis, T. and Pothoulakis, C. (2012). "Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders." Therapeutic Advances in Gastroenterology.
3. Vandenplas, Y., Brunser, O., and Szajewska, H. (2009). "Saccharomyces boulardii in childhood." European Journal of Pediatrics.
Gain access to your own data driven dashboard, health reports and personalised supplement plans.